Ronald Parsons, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Philadelphia, PANPI 1508913252
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,694 of the $10,042 with a category attached, or 86.6%. Intuitive Surgical accounts for 97.0% of it on its own, with 4 other manufacturers making up the rest.
Across 28 payments — averaging $358.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Sanofi-aventis U.S. LLC$118
- E.r. Squibb & Sons, L.L.C.$92
- Johnson & Johnson$69
- Baxter Healthcare$24
Across 52 payments — averaging $1378.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$72K
What the payments were for
- Travel & lodging$7898%
- Food & beverage$5596%
- Education$8,69487%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $9,739 |
| Sanofi-aventis U.S. LLC | 1 | $118 |
| E.r. Squibb & Sons, L.L.C. | 1 | $92 |
| Johnson & Johnson | 3 | $69 |
| Baxter Healthcare | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$8,500
- Da Vinci Surgical System$915
- THYMOGLOBULIN$118
How this compares
$10,042 in reported general payments places this provider in the 65th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nifedipine ErNifedipine | 15 | $198 |
| Prednisone | 31 | $159 |
| Atorvastatin Calcium | 29 | $125 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Philadelphia
- Mark AndersonPhiladelphia$527K
- Michael AckerPhiladelphia$271K
- Wilson SzetoPhiladelphia$252K
- Nimesh DesaiPhiladelphia$203K
- Nathaniel EvansPhiladelphia$187K
- Marisa CevascoPhiladelphia$186K
- Pavan AtluriPhiladelphia$165K
- Chase BrownPhiladelphia$137K
- Olugbenga OkusanyaPhiladelphia$132K
- Michael IbrahimPhiladelphia$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.